ROCKVILLE, Md., Oct. 15, 2025 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following investor conferences: Chardan’s 9th Annual Genetic Medicines Conference Panel “Battleground States for Muscular Dystrophies”: Tuesday, October […]
Financing will support the full execution of Phase Ib proof-of-mechanism study of MTX325 in patients with Parkinson’s disease (PD) Comes after successful completion of Phase 1a studies of MTX325, a first-in-class and potentially disease-modifying treatment […]
VIENNA, Oct. 15, 2025 /PRNewswire/ — The 61st Annual Meeting of the European Association for the Study of Diabetes (EASD 2025) was successfully held in Vienna, Austria. During the conference, Sinocare hosted an international industry […]
SAN FRANCISCO, Oct. 14, 2025 /PRNewswire/ — Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating […]
ENGLEWOOD, Colo., Oct. 14, 2025 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the […]
